Search - tctmd.com

Displaying 481 - 500 of 602

Sort: Relevancy | Date

Presentation TCT 2012

Vincristine Local Delivery for Renal Artery Denervation

Presenter: Christodoulos Stefanadis

October 24, 2012

Presentation TCT 2012

V2 (Vessix Vascular)

Presenter: James Margolis

October 24, 2012

Presentation TCT 2012

Translational Medicine and Renal Denervation: Preclinical Animal Models and Histoanatomy

Presenter: Renu Virmani

October 24, 2012

Presentation TCT 2012

TIVUS (CardioSonic)

Presenter: Dierk Scheinert

October 24, 2012

Presentation TCT 2012

Three-Year Results from SYMPLICITY HTN-1 and SYMPLICITY HTN-2: What the Data Do (and Don't) Tell Us

Presenter: Michael Bohm

October 24, 2012

Presentation TCT 2012

The Clinical Use of Renal Denervation Is Already Expanding Beyond Trial Indications: Insights from the German GREAT Registry

Presenter: Felix Mahfoud

October 24, 2012

Presentation TCT 2012

Systolic and Diastolic Heart Failure

Presenter: Justin Davies

October 24, 2012

Presentation TCT 2012

SYMPLICITY Results Are Too Good to Be True: That's Why We Need a Sham Trial Design!

Presenter: Darrel Francis

October 24, 2012

Presentation TCT 2012

Sympathetic Renal Denervation: 6 Month Results of the EnligHTN I Study (St. Jude Medical)

Presenter: Vasilios Papademetriou

October 24, 2012

Presentation TCT 2012

Sound Intervention

Presenter: Vivek Reddy

October 24, 2012

Presentation TCT 2012

Sham Trials Are Burdensome and Introduce Their Own Errors!

Presenter: Deepak Bhatt

October 24, 2012

Presentation TCT 2012

Resistant Hypertension: Prevalence and Global Impact

Presenter: Stefan Bertog

October 24, 2012

Presentation TCT 2012

Renal Sympathetic Denervation as the "Ideal Target" for Refractory Hypertension: Anatomy and Pathophysiology

Presenter: Michael Bohm

October 24, 2012

Presentation TCT 2012

Renal Artery Stenting: What Are the Indications for Intervention in 2012?

Presenter: Christopher White

October 24, 2012

Presentation TCT 2012

Properties of My Dream Device

Presenter: Horst Sievert

October 24, 2012

Presentation TCT 2012

Physiologic Rationale for Interventional Therapies in Hypertension

Presenter: C. Venkata S. Ram

October 24, 2012

Presentation TCT 2012

Paradise (ReCor)

Presenter: Karl-Heinz Kuck

October 24, 2012

Presentation TCT 2012

OneShot (Maya Medical)

Presenter: John Ormiston

October 24, 2012

Presentation TCT 2012

Obstructive Sleep Apnea

Presenter: Adam Witkowski

October 24, 2012

Presentation TCT 2012

Moderate Hypertension and ESRD

Presenter: Markus Schlaich

October 24, 2012

Advertisement

Vincristine Local Delivery for Renal Artery Denervation

V2 (Vessix Vascular)

Translational Medicine and Renal Denervation: Preclinical Animal Models and Histoanatomy

TIVUS (CardioSonic)

Three-Year Results from SYMPLICITY HTN-1 and SYMPLICITY HTN-2: What the Data Do (and Don't) Tell Us

The Clinical Use of Renal Denervation Is Already Expanding Beyond Trial Indications: Insights from the German GREAT Registry

Systolic and Diastolic Heart Failure

SYMPLICITY Results Are Too Good to Be True: That's Why We Need a Sham Trial Design!

Sympathetic Renal Denervation: 6 Month Results of the EnligHTN I Study (St. Jude Medical)

Sound Intervention

Sham Trials Are Burdensome and Introduce Their Own Errors!

Resistant Hypertension: Prevalence and Global Impact

Renal Sympathetic Denervation as the "Ideal Target" for Refractory Hypertension: Anatomy and Pathophysiology

Renal Artery Stenting: What Are the Indications for Intervention in 2012?

Properties of My Dream Device

Physiologic Rationale for Interventional Therapies in Hypertension

Paradise (ReCor)

OneShot (Maya Medical)

Obstructive Sleep Apnea

Moderate Hypertension and ESRD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content